*  FABP1 - Wikipedia
Fatty Acid-Binding Protein 1). It is also frequently known as liver-type fatty acid-binding protein (LFABP). FABP1 is primarily ... "Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding ... "Human liver fatty acid binding protein cDNA and amino acid sequence. Functional and evolutionary implications". Journal of ... "Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine ...
  https://en.wikipedia.org/wiki/FABP1
*  Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary...
Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The ... Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS ONE. 2011;6:e27356. ... Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489-503. ... Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. ...
  http://atvb.ahajournals.org/content/32/9/2327
*  No evidence to support or refute probiotics for patients with non-alcoholic fatty liver disease and/or steatohepatitis |...
No evidence to support or refute the effect of bile acids in patients with non-alcoholic fatty liver disease and/or ... No evidence to support or refute probiotics for patients with non-alcoholic fatty liver disease and/or steatohepatitis. ... Non-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic ... This review did not identify any randomised clinical trials with probiotics in non-alcoholic fatty liver disease and non- ...
  http://www.cochrane.org/CD005165/LIVER_no-evidence-to-support-or-refute-probiotics-for-patients-with-non-alcoholic-fatty-liver-disease-andor-steatohepatitis
*  Heart-type fatty acid binding protein - Wikipedia
... liver and small intestine are even lower again. H-FABP is recommended to be measured with troponin to identify myocardial ... Azzazy HM, Pelsers MM, Christenson RH (Jan 2006). "Unbound free fatty acids and heart-type fatty acid-binding protein: ... H-FABP is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for ... "Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty ...
  https://en.wikipedia.org/wiki/Heart-type_fatty_acid_binding_protein
*  FABP6 - Wikipedia
... the liver fatty acid binding protein) are also able to bind bile acids. It is thought that FABPs roles include fatty acid ... Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and ... FABP6 fatty acid binding protein 6, ileal (gastrotropin)". Börchers T, Hohoff C, Buhlmann C, Spener F (1997). "Heart-type fatty ... Fatty acid binding protein 6, ileal (gastrotropin), also known as FABP6, is a protein which in humans is encoded by the FABP6 ...
  https://en.wikipedia.org/wiki/FABP6
*  Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
Y. Xie, M. Wang, Y. Zhang et al., "Serum uric acid and non-alcoholic fatty liver disease in non-diabetic chinese men," PLoS ONE ... Y.-J. Lee, H.-R. Lee, J.-H. Lee, Y.-H. Shin, and J.-Y. Shim, "Association between serum uric acid and non-alcoholic fatty liver ... Y. Li, C. Xu, C. Yu, L. Xu, and M. Miao, "Association of serum uric acid level with non-alcoholic fatty liver disease: a cross- ... D.-Q. Sun, S.-J. Wu, W.-Y. Liu et al., "Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease," Expert ...
  https://www.hindawi.com/journals/jdr/2016/3805372/ref/
*  Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.
Nonalcoholic fatty liver disease is the most common chronic liver disease in the world, and is becoming increasingly prevalent ... Hepatic enzyme activities involved in fatty acid ?-oxidation The mitochondrial fatty acid ?-oxidation in liver was suppressed ... Besides the genes involved in fatty acid de novo synthesis, the genes involved in fatty acid ?-oxidation, like PPAR? and its ... suggesting that the inhibition of hepatic endogenous fatty acid synthesis may partly explain why SSC alleviated fatty liver. ...
  http://www.biomedsearch.com/nih/Dietary-saponins-sea-cucumber-alleviate/20211032.html
*  Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target.
It may progress to liver cirrhosis and liver cancer and is poised to represent the most common indication for liver ... is currently evolving as the most common liver disease worldwide. ... Once the capacity of the liver to store fatty acids in form of triglycerides is overwhelmed, NASH, differentiated from a fatty ... of free fatty acids from the circulation, the daily input of triglycerides from diet and fatty acids from adipocyte tissue is ...
  http://www.biomedsearch.com/nih/Non-alcoholic-Fatty-liver-disease/22187656.html
*  Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation...
Insulin resistance-related obesity and diabetes mellitus are the predominant causes of fatty liver disease. Here we examine the ... Fatty Liver / blood, metabolism, prevention & control*. Liver / drug effects, metabolism. Male. Organ Size / drug effects. ... Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation ... 0/Diglycerides; 0/Triglycerides; 0/fatty acid oxidation complex; 463-40-1/alpha-Linolenic Acid; 57-88-5/Cholesterol; EC 1.1. ...
  http://www.biomedsearch.com/nih/Supplementation-with-alpha-linolenic-acid/15863369.html
*  Bile acid uptake inhibitor prevents NASH/fatty liver in mice | Emory University | Atlanta, GA
The findings suggest that ASBT inhibitors could be a viable clinical strategy to address NASH, an increasingly common liver ... Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a ... Fatty liver disease is an increasing concern in many countries.. Giving mice a bile acid reuptake inhibitor prevented fat ... Bile acid uptake inhibitor prevents NASH/fatty liver in mice. Woodruff Health Sciences Center , Sept. 21, 2016 ...
  http://news.emory.edu/stories/2016/09/karpen_bile_acid_stm/
*  Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) - Tabular View - ClinicalTrials...
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) (EDACN). The safety and ... Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double- ... Nobili V, Alisi A, Della Corte C, Risé P, Galli C, Agostoni C, Bedogni G. Docosahexaenoic acid for the treatment of fatty liver ... Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD). ...
  https://clinicaltrials.gov/ct2/show/record/NCT00885313
*  Role of bioactive fatty acids in nonalcoholic fatty liver disease | Nutrition Journal | Full Text
Key: NAFLD, nonalcoholic liver disease; SCFA, short-chain fatty acid; MCFA, medium-chain fatty acid; LCFA, long-chain fatty ... The simplest n-6 fatty acid is linoleic acid (C18:2), while linolenic acid (C18:3) is the simplest n-3 fatty acid. Murine ... Polyunsaturated fatty acids. Polyunsaturated fatty acids (PUFAs) include linoleic acid (n-6), alpha-linolenic acid and ... Fatty acidsLiver diseasesNutritionRisk factors. Introduction. Nonalcoholic fatty liver disease (NAFLD) is a condition ...
  https://nutritionj.biomedcentral.com/articles/10.1186/s12937-016-0191-8
*  Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver...
Fatty liver disease (bright liver, hepatomegaly by ultrasound (Liver span , 15 cm mid clavicle line), splenomegaly (,13 cm) or ... Non-alcoholic fatty liver disease MedlinePlus related topics: Cholesterol Cholesterol Levels: What You Need to Know Fatty Liver ... Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver ... Liver Diseases. Non-alcoholic Fatty Liver Disease. Metabolic Diseases. Wolman Disease. Cholesterol Ester Storage Disease. ...
  https://clinicaltrials.gov/ct2/show/NCT01791452?term=Acid+Lipase+Disease&rank=10
*  Nutrients | Free Full-Text | Hepatic Oxidative Stress in Fructose-Induced Fatty Liver Is Not Caused by Sulfur Amino Acid...
In rodent models of fructose-mediated fatty liver, protein consumption is decreased. Additionally, decreased sulfur amino acid ... liquid-induced fatty liver is caused by decreased ad libitum solid food intake with associated inadequate sulfur amino acid ... We conclude that both fructose and glucose-sweetened liquid consumption results in fatty liver and upregulated thioredoxin-2 ... Fructose- and glucose-fed mice developed fatty liver. The mitochondrial antioxidant protein, thioredoxin-2, displayed decreased ...
  http://www.mdpi.com/2072-6643/3/11/987/xml
*  Phd Studentship: Bile Acid Synthesis in the Pathogenesis of non-alcoholic Fatty Liver Disease (NAFLD) and Liver Cancer at...
Bile Acid Synthesis in the Pathogenesis of non-alcoholic Fatty Liver Disease (NAFLD) and Liver Cancer job... ... Phd Studentship: Bile Acid Synthesis in the Pathogenesis of non-alcoholic Fatty Liver Disease (NAFLD) and Liver Cancer. Oxford ... Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic disease. Not only is NAFLD ... We know that bile acid synthesis is disrupted in patients with NAFLD and, as bile acid signalling is cytoprotective, we ...
  http://www.jobs.ac.uk/job/BGH609/phd-studentship-bile-acid-synthesis-in-the-pathogenesis-of-non-alcoholic-fatty-liver-disease-nafld-and-liver-cancer/
*  Fatty liver, elevated cholesterol, high uric acid level. Prescribed Golbi and Zyloric. How long to cure?
How long to cure?. Ask a Doctor about diagnosis, treatment and medication for Fatty liver, Ask a Gastroenterologist ... high uric acid level. Prescribed Golbi and Zyloric. ... The fatty liver/ enlarged liver (16.5 c.m.), elevated uric acid ... I have fatty liver and elevated level of cholesterol (LDL) along with marginally high level of Uric Acid. I have been ... Follow-up: Fatty liver, elevated cholesterol, high uric acid level. Prescribed Golbi and Zyloric. How long to cure? 10 hours ...
  http://www.healthcaremagic.com/premiumquestions/Fatty-liver-elevated-cholesterol-high-uric-acid-level-Prescribed-Golbi-and-Zyloric-How-long-to-cure/28794
*  Improvement Effect of Fermented Orostachys malacophyllus against Orotic Acid-induced Fatty Liver Model Rats | Korea Science
... fatty liver;lactic acid bacteria;Orostachys malacophyllus;orotic acid; ... Improvement Effect of Fermented Orostachys malacophyllus against Orotic Acid-induced Fatty Liver Model Rats - Fermentation; ... Improvement Effect of Fermented Orostachys malacophyllus against Orotic Acid-induced Fatty Liver Model Rats. Ahn, Hee-Young; ... Improvement Effect of Fermented Orostachys malacophyllus against Orotic Acid-induced Fatty Liver Model Rats ...
  http://www.koreascience.or.kr/article/ArticleFullRecord.jsp?cn=SMGHBM_2015_v25n8_917
*  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. - Semantic...
Recent literature suggests that elevated free fatty acids (FFAs), especially saturated FFAs, may play an important role in ... has been closely linked to significant increases in a multitude of accompanying health problems including non-alcoholic fatty ... liver disease (NAFLD). NAFLD severity ranges from simple steatosis to acute steatohepatitis, but the molecular mechanisms ... Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.. @article{ ...
  https://www.semanticscholar.org/paper/Molecular-mechanisms-and-the-role-of-saturated-in-Leamy-Egnatchik/162a2f772708cd9b341ae88389d28bfb40adc9af
*  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double...
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double- ... Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double- ... decreases liver fat content in children with non-alcoholic fatty liver disease (NAFLD). ... Main outcome measures The main outcome was the change in liver fat content as detected by ultrasonography after 6 months of ...
  http://adc.bmj.com/content/96/4/350
*  Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and 122 alter its structural integrity and...
Thumser, AEA, Voysey, J and Wilton, DC (1996) Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and ... Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and 122 alter its structural integrity and ...
  http://epubs.surrey.ac.uk/821855/
*  Binding of recombinant rat liver fatty acid-binding protein to small anionic phospholipid vesicles results in ligand release: A...
Davies, JK, Thumser, AEA and Wilton, DC (1999) Binding of recombinant rat liver fatty acid-binding protein to small anionic ... Binding of recombinant rat liver fatty acid-binding protein to small anionic phospholipid vesicles results in ligand release: A ... A model for interfacial binding and fatty acid targeting BIOCHEMISTRY, 38 (51). pp. 16932-16940. ...
  http://epubs.surrey.ac.uk/821259/
*  Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats.
... administration on liver regeneration after 90% partial hepatectomy (PH) in rats. ω-3 PUFAs were intravenously injected in the ω ... To evaluate the effectiveness of omega-3 polyunsaturated fatty acid (ω-3 PUFA) ... CONCLUSION: Omega-3 polyunsaturated fatty acids may prevent acute liver failure and promote liver regeneration after 90% ... AIM: To evaluate the effectiveness of omega-3 polyunsaturated fatty acid (ω-3 PUFA) administration on liver regeneration after ...
  http://www.biomedsearch.com/nih/Omega-3-polyunsaturated-fatty-acids/22783054.html
*  Liver Microsomal Fatty Acid Composition in Ethanol-Fed Rats: Effect of Different Dietary Fats and Relationship to Liver Injury ...
... Thus, diet-dependent differences in liver microsomal fatty acid composition may help to explain why ethanol-induced liver ... Fatty Acid omega- and (omega-1)-Hydroxylation in Experimental Alcoholic Liver Disease: Relationship to Different Dietary Fatty ... model for alcoholic liver disease was used to study the effect of different diets on the fatty acid composition of liver ...
  http://onlinelibrary.wiley.com/doi/10.1111/j.1530-0277.1994.tb00077.x/abstract
*  Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine...
We examined the early changes in sulfur-amino acid metabolism and their implication in nonalcoholic fatty liver disease (NAFLD ... but its role in nonalcoholic fatty liver remains unknown. ... Antioxidant capacity of liver cytosol against hydroxyl and ... Betaine supplementation protects the liver from nonalcoholic steatosis and oxidative stress most probably via its effects on ... Impairment of hepatic transsulfuration reactions is suggested to be critically linked with alcoholic liver injury, ...
  https://www.semanticscholar.org/paper/Impaired-sulfur-amino-acid-metabolism-and-oxidative-Kwon-Jung/3b661ce8bf26569c3ee80412d923cd9dbd753770